financial inefficiencies

By the time Josh Schwartz arrived at Medidata, the life sciences innovation company had found itself entering unfamiliar waters. Having just gone public, the firm was shifting away from being a fast-growing start-up to welcoming life as a more structured, scalable organization. For Schwartz, who initially led revenue recognition, this was the beginning of both…